ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model.

Emily Z Huie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.